Global manufacturer of durable medical equipment (DME) Medical Depot Holdings Inc. (also known as Drive DeVilbiss Healthcare) experienced an unfavorable shift in customer and channel mix as well as greater pricing pressure in certain product categories, which is weighing on margins. We are lowering our 2017 EBITDA estimate by about $20 million, to $70 million, which increases 2017 debt leverage to about 10.4x; we expect modest free cash flow deficits for 2017. We are lowering our corporate credit rating on Medical Depot to 'B-' from 'B'. The outlook is negative. At the same time, we are lowering our rating on the first-lien debt to 'B-' from 'B', and our rating on the second-lien debt to 'CCC' from 'CCC+'. Our recovery